Abstract
Objective
The aim of this study was to investigate the interaction of sex steroid hormones, particularly oestrogen, in the regulation of prepulse inhibition (PPI) by serotonin-1A (5-HT1A) receptors.
Materials and methods
We studied aromatase knockout (ArKO) mice, which are unable to produce oestrogen but have high levels of testosterone, and the effects of castration.
Results and discussion
Treatment of male ArKO mice with the 5-HT1A receptor agonist, 8-hydroxy-dipropyl-aminotetralin (8-OH-DPAT), caused an increase in PPI that was significantly greater than in male wild-type controls. Castration of male mice caused a significant enhancement of the effect of 8-OH-DPAT in control mice; however, there was no change in the effect of this drug in ArKO mice. There was no significant effect of 8-OH-DPAT on PPI in either female ArKO or wild-type controls. In all experiments, the effects of 8-OH-DPAT on startle were not different between the groups. [3H]8-OH-DPAT autoradiography showed no differences in 5-HT1A receptor binding densities in areas of the forebrain, hippocampus or raphe region that could explain the PPI results. These data show that the absence of oestrogen in male ArKO mice leads to a greater effect of 5-HT1A receptor stimulation on PPI. This effect can be mimicked in male control mice by castration. The differential involvement of oestrogen and testosterone in these animal models is discussed.
Similar content being viewed by others
References
Bertrand PP, Paranavitane UT, Chavez C, Gogos A, Jones M, van den Buuse M (2005) The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res 1064:10–20
Bonson KR, Johnson RG, Fiorella D, Rabin RA, Winter JC (1994) Serotonergic control of androgen-induced dominance. Pharmacol Biochem Behav 49:313–322
Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234–258
Britt KL, Drummond AE, Cox VA, Dyson M, Wreford NG, Jones MEE, Simpson ER, Findlay JK (2000) An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 141:2614–2623
Cyr M, Landry M, Di Paolo T (2000) Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 23:69–78
Czyrak A, Mackowiak M, Chocyk A, Fijal K, Gadek-Michalska A, Wedzony K (2003) 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment. Neuropsychopharmacology 28:1300–1310
Dalla C, Antoniou K, Papadopoulou-Daifoti Z, Balthazart J, Bakker J (2004) Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. Eur J Neurosci 20:217–228
Davies MA, Sheffler DJ, Roth BL (2004) Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev 10:317–336
Dean B, Tomaskovic-Crook E, Opeskin K, Keks N, Copolov D (1999) No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia. Neurochem Int 34:109–115
Di Paolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5:27–42
Dulawa SC, Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170–2179
Dulawa SC, Scearce-Levie KA, Hen R, Geyer MA (2000) Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice. Neuropsychopharmacology 149:306–312
Etgen AM, Ungar S, Petitti N (1992) Estradiol and progesterone modulation of norepinephrine neurotransmission: implications for the regulation of female reproductive behavior. J Neuroendocrinol 4:255–271
Fink G, Sumner B, Rosie R, Wilson H, McQueen J (1999) Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105:53–68
Fisher CR, Graves KH, Parlow AF, Simpson ER (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 95:6965–6970
Fitch RH, Denenberg VH (1998) A role for ovarian hormones in sexual differentiation of the brain. Behav Brain Sci 21:311–352
Franklin KBJ, Paxinos A (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego
Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 787–798
Gogos A, van den Buuse M (2003) Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav Neurosci 117:1407–1415
Gogos A, van den Buuse M (2004) Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-OH-DPAT. J Pharmacol Exp Ther 309:267–274
Gogos A, Kusljic S, van den Buuse M (2005) 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81:664–672
Gogos A, Nathan PJ, Guille V, Croft RJ, van den Buuse M (2006) Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31:885–889
Gore AC (2001) Gonadotropin-releasing hormone neurons, NMDA receptors, and their regulation by steroid hormones across the reproductive life cycle. Brain Res Brain Res Rev 37:235–48
Halbreich U, Kahn LS (2003) Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28:1–16
Hill RA, Pompolo S, Jones ME, Simpson ER, Boon WC (2004) Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice. Mol Cell Neurosci 27:466–476
Hjorth S, Sharp T (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48:1779–1786
Kreiss DS, Lucki I (1994) Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther 269:1268–1279
Landry M, Di Paolo T (2003) Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Mol Brain Res 112:82–89
Le Saux M, Di Paolo T (2005) Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J Psychiatry Neurosci 30:110–117
Luine VN, Grattan DR, Selmanoff M (1997) Gonadal hormones alter hypothalamic GABA and glutamate levels. Brain Res 747:165–168
Martin S, Jones ME, Simpson ER, van den Buuse M (2003) Impaired spatial working memory in aromatase-deficient (ArKO) mice. Neuroreport 14:1979–1982
McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD (2003) Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 23:8701–8705
McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP (2001) Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 142:2458–2467
Mize AL, Young LJ, Alper RH (2003) Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology 44:584–591
National Health and Medical Research Council of Australia (1990) Australian code of practice for the care and use of animals for scientific purposes. Australian Government Publishing Services, Canberra
Olivier B, Leahy C, Mullen T, Paylor R, Groppi VE, Sarnyai Z, Brunner D (2001) The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology 156:284–290
Pavey GM, Copolov DL, Dean B (2002) High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding. J Neurosci Methods 116:157–163
Riecher-Rössler A (2002) Oestrogen effects in schizophrenia and their potential therapeutic implications—review. Arch Womens Ment Health 5:111–118
Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R (1994) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20:203–214
Robertson KM, O’Donnell L, Jones MEE, Meachem SJ, Boon WC, Fischer CR, Graves KH, McLachlan RI, Simpson ER (1999) Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 96:7986–7991
Sakaue M, Ago Y, Baba A, Matsuda T (2003) The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170:73–79
Seeman MV (1997) Psychopathology in women and men: focus on female hormones. Am J Psychiatr 154:1641–1647
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185–194
Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225–230
Sipes TA, Geyer MA (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117:41–48
van den Buuse M, Eikelis N (2001) Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425:33–41
van den Buuse M, Wegener N (2005) Involvement of serotonin1A receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains. Eur J Pharmacol 507:187–198
van den Buuse M, Simpson ER, Jones ME (2003) Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender. Genes Brain Behav 2:93–102
van den Buuse M, Morris M, Chavez C, Martin S, Wang JH (2004) Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice. Br J Pharmacol 142:543–550
van den Buuse M, van Driel IR, Samuelson LC, Pijnappel M, Martin S (2005) Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice. Neurosci Lett 373:237–242
Acknowledgments
The authors are grateful to Udeni Paranavitane for assistance with some of the experiments. Dr. M. van den Buuse was supported by the Griffith Senior Research Fellowship of the University of Melbourne. This study was supported by the National Health and Medical Research Council of Australia. The Mental Health Research Institute is a Stanley Research Centre, supported by the Stanley Medical Research Institute. All experiments described in this paper comply with the current laws of Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gogos, A., Martin, S., Jones, M.E. et al. Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice. Psychopharmacology 188, 100–110 (2006). https://doi.org/10.1007/s00213-006-0472-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0472-6